Misoprostol Vaginal Insert and Time to Vaginal Delivery: A Randomized Controlled Trial
@article{Wing2013MisoprostolVI,
title={Misoprostol Vaginal Insert and Time to Vaginal Delivery: A Randomized Controlled Trial},
author={Deborah A. Wing and Raymond Brown and Lauren A. Plante and Hugh S. Miller and Olof Rugarn and Barbara L. Powers},
journal={Obstetrics \& Gynecology},
year={2013},
volume={122},
pages={201–209}
}OBJECTIVE: To compare the efficacy and safety of a 200-microgram misoprostol vaginal insert with a 10-mg dinoprostone vaginal insert for reducing the time to vaginal delivery. METHODS: In a phase III, double-blind, multicenter study, women being induced with a modified Bishop score of 4 or less were randomly assigned to receive either a 200-microgram misoprostol vaginal insert or a 10-mg dinoprostone vaginal insert. Coprimary end points were time to vaginal delivery and rate of cesarean…
Topics from this paper
83 Citations
Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study
- Medicine, BiologyBMC Pregnancy and Childbirth
- 2018
MVI achieves a more vaginal delivery rate within 24 h and Tachysystole events compared to MVT, however, no differences in caesarean section, operative vaginal delivery, and neonatal outcomes are reported.
Misoprostol vaginal insert versus dinoprostone vaginal insert: A comparison of labour and delivery outcomes.
- MedicineEuropean journal of obstetrics, gynecology, and reproductive biology
- 2019
A critical appraisal of the misoprostol removable, controlled-release vaginal delivery system of labor induction
- MedicineInternational journal of women's health
- 2015
Current data suggest that the 100 μg MVI would provide the best balance between efficacy and safety, especially in high-risk situations needing induction of labor.
Oral misoprostol, low dose vaginal misoprostol, and vaginal dinoprostone for labor induction: Randomized controlled trial
- MedicinePloS one
- 2020
There was no significant difference in effectiveness of the three groups of induction at randomization, andound newborn acidemia, though infrequent, occurred only with low dose vaginal misoprostol.
Initial clinical experience with a misoprostol vaginal insert in comparison with a dinoprostone insert for inducing labor.
- MedicineEuropean journal of obstetrics, gynecology, and reproductive biology
- 2016
Efficacy and safety of misoprostol vaginal insert vs. oral misoprostol for induction of labor
- MedicineJournal of perinatal medicine
- 2019
Time to delivery was significantly shorter in the MVI group with a higher rate of vaginal deliveries within the first 24 h, however, patients needed more opioids for pain relief during induction with MVI, and there was no difference in neonatal outcomes.
A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study
- MedicineBMC Pregnancy and Childbirth
- 2018
In a setting of routine obstetric care, MVI seems to be a more efficient labor induction agent than MVT, and with a lower CS rate and no increase in adverse infant outcomes.
The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study
- MedicineJournal of perinatal medicine
- 2018
The MVI compared with OM significantly shortened the time from application to delivery at the expense of a higher cesarean section rate and negative effects on neonatal outcomes.
Clinical experience with misoprostol vaginal insert for induction of labor: a prospective clinical observational study
- MedicineArchives of Gynecology and Obstetrics
- 2018
When clinically indicated, MVI was efficient and safe for induction of labor in women with an unfavorable cervix, however, women should be counseled regarding the risk of uterine tachysystole prior to labor induction with MVI.
Standard and adjusted criteria for the use of the misoprostol vaginal insert for labor induction: a comparative cohort study
- MedicineJournal of perinatal medicine
- 2019
The time from induction to delivery with MVI was similar when using standard criteria of up to 24 h of exposure vs. adjusted criteria ofup to 10 h of Exposure, and although the threshold for statistical significance for cesarean section was not attained, there is nonetheless a considerable difference between the MVI-24 and M VI-10 groups.
References
SHOWING 1-10 OF 21 REFERENCES
Misoprostol Vaginal Insert Compared With Dinoprostone Vaginal Insert: A Randomized Controlled Trial
- MedicineObstetrics and gynecology
- 2008
The misoprostol vaginal insert 100 and the dinoprostone vaginal insert had similar median time intervals to vaginal delivery, whereas the misopral vaginal insert 50 had a significantly longer time to vaginal Delivery.
Pharmacokinetic Profiles of Controlled‐Release Hydrogel Polymer Vaginal Inserts Containing Misoprostol
- MedicineJournal of clinical pharmacology
- 2008
The pharmacokinetic profiles of these vaginal inserts and orally administered misoprostol were investigated to address uncertainty regarding the correct dose and the difficulty in removing the product when there is an adverse event.
Vaginal misoprostol for cervical ripening and induction of labour.
- MedicineThe Cochrane database of systematic reviews
- 2003
Vaginal misoprostol labour induction was associated with less epidural analgesia use, fewer failures to achieve vaginal delivery within 24 hours and more uterine hyperstimulation.
Vaginal misoprostol for cervical ripening and induction of labour.
- MedicineThe Cochrane database of systematic reviews
- 2010
Vaginal misoprostol in doses above 25 mcg four-hourly was more effective than conventional methods of labour induction, but with more uterine hyperstimulation, and lower doses were similar to conventional methods in effectiveness and risks.
Women's perceptions, expectations and satisfaction with induced labour--a questionnaire-based study.
- MedicineEuropean journal of obstetrics, gynecology, and reproductive biology
- 2005
THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS
- Medicine
- 2006
This Practice Bulletin is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care and should not be construed as dictating an exclusive course of treatment or procedure.
Births: final data for 2009.
- MedicineNational vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System
- 2011
This report presents 2009 data on U.S. births according to a wide variety of characteristics, including age, live-birth order, race and Hispanic origin, marital status, hypertension during pregnancy, attendant at birth, method of delivery, and infant characteristics.